Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00226330
Status:
TERMINATED
Last Update Posted:
2010-11-19
First Post:
2005-09-23
Brief Title:
GALLEX 6 Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetes Mellitus Type 2 |
Keywords:
| Name | View |
|---|---|
| Patients diagnosed with type 2 diabetes who have participated in and completed the randomized double-blind parallel-group multi-center study GALLANT 6 | View |